|
HUE033325T2
(en)
*
|
2007-01-05 |
2017-11-28 |
Univ Zuerich |
Anti-beta-amyloid binder antibodies and their use
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
KR20100115340A
(ko)
*
|
2007-10-19 |
2010-10-27 |
이무나스 파마 가부시키가이샤 |
Ａβ 올리고머에 특이적으로 결합하는 항체 및 그의 이용
|
|
PL2246427T3
(pl)
|
2008-02-08 |
2017-06-30 |
Immunas Pharma, Inc. |
Przeciwciała zdolne do wiązania się swoiście do oligomerów amyloidu beta i ich stosowanie
|
|
WO2010004434A2
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
HRP20150831T1
(hr)
|
2008-12-19 |
2015-10-09 |
Biogen International Neuroscience Gmbh |
Humana anti-alfa- sinuklein auto-protutijela
|
|
JP5812418B2
(ja)
|
2009-04-17 |
2015-11-11 |
イムナス・ファーマ株式会社 |
Ａβオリゴマーに特異的に結合する抗体およびその利用
|
|
CN102596997B
(zh)
|
2009-08-06 |
2015-06-03 |
伊缪纳斯制药株式会社 |
特异性结合Aβ寡聚体的抗体及其用途
|
|
CN105777907B
(zh)
|
2010-02-24 |
2020-03-17 |
伊缪诺金公司 |
叶酸受体1抗体与免疫缀合物以及其用途
|
|
KR20200023495A
(ko)
|
2011-01-10 |
2020-03-04 |
더 리젠츠 오브 더 유니버시티 오브 미시간 |
줄기 세포 인자 억제제
|
|
EP3252076B1
(en)
|
2011-01-14 |
2019-09-04 |
The Regents Of The University Of California |
Diagnostic use of antibodies against ror-1 protein
|
|
ES2661466T3
(es)
|
2011-04-01 |
2018-04-02 |
Immunogen, Inc. |
Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1
|
|
PL2723379T3
(pl)
|
2011-06-23 |
2019-05-31 |
Biogen Int Neuroscience Gmbh |
Cząsteczki wiążące przeciwko alfa-synukleinie
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
WO2013040472A2
(en)
*
|
2011-09-16 |
2013-03-21 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods related to dna damage repair
|
|
SG11201500938XA
(en)
|
2012-08-31 |
2015-04-29 |
Immunogen Inc |
Diagnostic assays and kits for detection of folate receptor 1
|
|
AU2013361275B2
(en)
*
|
2012-12-19 |
2016-11-24 |
Amplimmune, Inc. |
Anti-human B7-H4 antibodies and their uses
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
WO2015006554A1
(en)
*
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
WO2015027120A1
(en)
*
|
2013-08-21 |
2015-02-26 |
Jiang Jean X |
Compositions and methods for targeting connexin hemichannels
|
|
NZ717140A
(en)
|
2013-08-30 |
2022-05-27 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
|
EP3054974A4
(en)
*
|
2013-10-10 |
2017-06-14 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CA2924520C
(en)
*
|
2013-11-01 |
2023-09-26 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
EP3105251A4
(en)
*
|
2014-02-10 |
2017-11-15 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
|
US10401368B2
(en)
|
2014-03-20 |
2019-09-03 |
Pdl Biopharma, Inc. |
Antibodies and methods for the detection of cell death
|
|
ES2772817T3
(es)
*
|
2014-04-10 |
2020-07-08 |
Obi Pharma Inc |
Anticuerpos de unión a antígenos de carbohidrato asociados a tumor, composiciones farmacéuticas y sus usos
|
|
CA2957722C
(en)
|
2014-08-19 |
2022-05-31 |
Merck Sharp & Dohme Corp. |
Anti-tigit antibodies
|
|
TN2017000066A1
(en)
*
|
2014-09-16 |
2018-07-04 |
Ovascience Inc |
Anti-vasa antibodies, and methods of production and use thereof.
|
|
JP2017536102A
(ja)
*
|
2014-10-16 |
2017-12-07 |
ジェネンテック， インコーポレイテッド |
抗アルファ−シヌクレイン抗体及び使用方法
|
|
MX2017006167A
(es)
|
2014-11-12 |
2018-03-23 |
Siamab Therapeutics Inc |
Compuestos que interactúan con glicanos y métodos de uso.
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
ES2870983T3
(es)
*
|
2014-12-19 |
2021-10-28 |
Univ Nantes |
Anticuerpos anti-IL-34
|
|
AU2016210835B2
(en)
*
|
2015-01-29 |
2021-01-21 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
US10494425B2
(en)
*
|
2015-02-24 |
2019-12-03 |
Rpeptide, Llc |
Anti-amyloid-beta antibodies
|
|
WO2016145022A1
(en)
*
|
2015-03-11 |
2016-09-15 |
The Board Of Regents Of The University Of Texas System |
Anti-dc-hil antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
EP3273994B1
(en)
|
2015-03-27 |
2021-12-01 |
University of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
|
US10487153B2
(en)
*
|
2015-06-10 |
2019-11-26 |
National Research Council Of Canada |
Carbonic anhydrase IX-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
CN115925931A
(zh)
|
2015-08-14 |
2023-04-07 |
默沙东公司 |
抗tigit抗体
|
|
RU2760582C2
(ru)
*
|
2015-09-02 |
2021-11-29 |
Иммутеп С.А.С. |
Анти-LAG-3 антитела
|
|
CN122075735A
(zh)
|
2015-09-17 |
2026-05-26 |
伊缪诺金公司 |
包含抗folr1免疫缀合物的治疗组合
|
|
KR102964291B1
(ko)
|
2015-11-09 |
2026-05-13 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타 에피토프 및 이에 대한 항체
|
|
CA3004482A1
(en)
|
2015-11-09 |
2017-05-18 |
Neil R. Cashman |
N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
|
|
US10774120B2
(en)
|
2015-11-09 |
2020-09-15 |
The University Of British Columbia |
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
|
|
CA3002097A1
(en)
|
2015-11-12 |
2017-05-18 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
MX2018010485A
(es)
|
2016-03-04 |
2019-01-10 |
Jn Biosciences Llc |
Anticuerpos para inmunoreceptor de celulas t con dominios de ig e itim (tigit).
|
|
EP3430046A4
(en)
*
|
2016-03-16 |
2019-10-23 |
Abeome Corporation |
NEUTRALIZING MONOCLONAL ANTIBODIES TO IL-25 AND USES THEREOF
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
CA3027942A1
(en)
*
|
2016-06-16 |
2017-12-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Humanized and chimeric monoclonal antibodies to cd81
|
|
KR102550991B1
(ko)
*
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
WO2018094143A1
(en)
|
2016-11-17 |
2018-05-24 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
WO2018098370A1
(en)
*
|
2016-11-23 |
2018-05-31 |
Immunoah Therapeutics, Inc. |
4-1bb binding proteins and uses thereof
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
EP3585403A4
(en)
*
|
2017-02-22 |
2020-12-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
CHEMERICAL ANTIGENIC RECEPTORS BINDING TO TIM3
|
|
US11274160B2
(en)
*
|
2017-03-02 |
2022-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Antibodies having specificity to Nectin-4 and uses thereof
|
|
KR20240044544A
(ko)
|
2017-03-03 |
2024-04-04 |
씨젠 인크. |
글리칸-상호작용 화합물 및 사용 방법
|
|
WO2018184558A1
(zh)
*
|
2017-04-05 |
2018-10-11 |
凯惠科技发展(上海)有限公司 |
一种人源化抗tpbg抗体及其制备方法、其偶联物和应用
|
|
JP7280238B2
(ja)
*
|
2017-07-17 |
2023-05-23 |
ヤンセン バイオテツク，インコーポレーテツド |
フィブロネクチンｉｉｉ型ドメインに対する抗原結合領域及びその使用方法
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
CN111201030B
(zh)
|
2017-07-25 |
2024-11-01 |
真和制药有限公司 |
通过阻断tim-3和其配体的相互作用治疗癌症
|
|
MD3672631T3
(ro)
|
2017-08-22 |
2023-09-30 |
Biogen Ma Inc |
Compoziții farmaceutice conținând anticorpi anti-beta amiloidici
|
|
TW202003576A
(zh)
*
|
2018-05-10 |
2020-01-16 |
美商艾博視訊有限公司 |
活化cd40之單株抗體及其用途
|
|
KR102523019B1
(ko)
*
|
2018-05-30 |
2023-04-18 |
내셔날 헬스 리서치 인스티튜트 |
항-a베타 항체 및 이의 용도
|
|
CN112368021B
(zh)
|
2018-06-14 |
2025-02-21 |
2赛文缇生物公司 |
Cd79a嵌合抗原受体
|
|
JP7623939B2
(ja)
*
|
2018-07-09 |
2025-01-29 |
マルチチュード インコーポレーテッド |
葉酸受容体アルファに特異的な抗体
|
|
EP3852779A4
(en)
|
2018-09-17 |
2022-06-08 |
Abcuro, Inc. |
ANTI-KLRG1 ANTIBODIES
|
|
WO2020156335A1
(zh)
*
|
2019-01-29 |
2020-08-06 |
上海交通大学 |
一种嵌合抗原受体及其应用
|
|
KR20210124308A
(ko)
|
2019-01-30 |
2021-10-14 |
트루바인딩 아이엔씨. |
항-gal3 항체 및 이의 용도
|
|
CA3132462A1
(en)
*
|
2019-03-02 |
2020-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
SG11202110504XA
(en)
|
2019-03-26 |
2021-10-28 |
Janssen Pharmaceutica Nv |
ANTIBODIES TO PYROGLUTAMATE AMYLOID-ß AND USES THEREOF
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
US12352719B2
(en)
|
2019-09-20 |
2025-07-08 |
KYCERA AVX Components Corporation |
Somatic cell-based electrical biosensor
|
|
EP4084826A2
(en)
*
|
2019-12-30 |
2022-11-09 |
University Of Louisville Research Foundation, Inc. |
Virus-like particle binding agents, related compositions, and related methods
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
WO2021231982A1
(en)
*
|
2020-05-14 |
2021-11-18 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
MX2022014786A
(es)
|
2020-05-26 |
2023-01-16 |
Truebinding Inc |
Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
|
|
TW202210514A
(zh)
|
2020-06-02 |
2022-03-16 |
美商阿克思生物科學有限公司 |
針對tigit的抗體
|
|
CN116723856A
(zh)
|
2020-06-25 |
2023-09-08 |
默沙东有限责任公司 |
靶向丝氨酸413处磷酸化的tau的高亲和力抗体
|
|
AU2021310926A1
(en)
|
2020-07-23 |
2023-03-23 |
Othair Prothena Limited |
Anti-abeta antibodies
|
|
CA3187837A1
(en)
*
|
2020-08-04 |
2022-02-10 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
IL300704A
(en)
*
|
2020-08-18 |
2023-04-01 |
Omeros Corp |
Monoclonal antibodies, preparations and methods for detecting complement factor D
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
US20240117047A1
(en)
*
|
2021-02-11 |
2024-04-11 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
WO2023076926A1
(en)
*
|
2021-10-26 |
2023-05-04 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatmycoses
|
|
US20260167739A1
(en)
*
|
2022-11-08 |
2026-06-18 |
Phanes Therapeutics, Inc. |
Anti-5t4 antibodies and uses thereof
|
|
US12534540B2
(en)
*
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
US20240352102A1
(en)
*
|
2023-01-27 |
2024-10-24 |
The United States Government As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
CN121464157A
(zh)
*
|
2023-02-28 |
2026-02-03 |
梅约医学教育与研究基金会 |
结合至b细胞活化因子受体多肽的分子
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
KR20260042555A
(ko)
*
|
2023-08-25 |
2026-03-31 |
키메드 바이오사이언시스 (청두) 컴퍼니 리미티드 |
알츠하이머병 치료제의 개발 및 용도
|
|
WO2026030622A1
(en)
*
|
2024-08-01 |
2026-02-05 |
Antharis Therapeutics Inc. |
Vista-binding antibodies and methods of use thereof
|
|
TW202620044A
(zh)
*
|
2024-09-12 |
2026-05-16 |
美商得納利醫療公司 |
抗β類澱粉蛋白抗體及使用方法
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|